PL
PL · PL · PL-100493821
Glycophos
ATC B05XA14
Last synced from URPL (Poland) on
Identification
ManufacturerInPharm Sp. z o.o.
CountryPL (PL)
ATC codeB05XA14
Dispensing—
ReimbursedNo
SourceURPL (Poland)
Last synced6/14/2026
Packs · 3
- gtin05909991532598
- gtin05909991532604
- gtin05909991532611
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Koncentrat do sporządzania roztworu do infuzji",
"source": "urpl",
"strength": "216 mg/ml",
"packaging": "05909991532598 ¦ Lz ¦ 153377\n10 fiol. 20 ml\n05909991532604 ¦ Lz ¦ 153378\n10 amp. 20 ml\n05909991532611 ¦ Lz ¦ 153379\n20 amp. 20 ml",
"substance": "Natrii glycerophosphas 216 mg/ml",
"common_name": "Natrii glycerophosphas",
"pl_product_id": "100493821",
"pozwolenie_nr": "077/24",
"auth_procedure": "IR",
"authorisation_validity": "2029-02-27"
}Related drugs
Other records sharing ATC code B05XA14.
- NOGlycophosFresenius Kabi
- FIGlycophosOrifarm Oy
- FIGlycophosFresenius Kabi AB
- DKGlycophosFresenius Kabi AB
- BEGlycophos 20 mlFresenius Kabi
- BEGlycophos 20 mlFresenius Kabi
- GBGlycophos 4.32g/20ml concentrate for solution for infusion vialsFresenius Kabi Ltd
- NLGlycophos, concentraat voor infusievloeistof 20 mlFresenius Kabi Nederland B.V.
Access this data programmatically
Query Glycophos and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.